MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2017 International Congress

    Altered attentional brain network in Parkinson’s disease with mild cognitive impairment

    J.H. Yang, K. McMahon, D. Copland, G. Byrne, A. Toft, L. Mithcell, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

    Objective: To investigate alterations in the attention network in Parkinson’s disease patients with mild cognitive impairment (PD-MCI). Background: MCI is a risk factor for dementia…
  • 2017 International Congress

    Increased hippocampal activation in Parkinson’s disease related amnestic mild cognitive impairment

    K. Perepezko, A. Gold, A. Bakker, G. Pontone, C. Speck, L. Rosenthal (Baltimore, MD, USA)

    Objective: To assess the functional significance of hippocampal network dysfunction in Parkinson’s disease related amnestic mild cognitive impairment (PD aMCI) using high-resolution functional neuroimaging. Background:…
  • 2017 International Congress

    APOE4+ status increases rate of longitudinal cognitive decline in Parkinson Disease patients with low CSF Aβ42

    K. Leaver, T. Hendershott, D. Zhu, L. Tian, K. Poston (Stanford, CA, USA)

    Objective: To determine if the presence of APOEɛ4 allele (APOE4+) predicts longitudinal cognitive decline in Parkinson’s disease (PD) patients with low CSFAβ42 Background: Cognitive impairment…
  • 2017 International Congress

    Olfactory deficits in the cognitive impaired de novo patients with Parkinson’s disease

    J.S. Baik, H.I. Ma (Seoul, Republic of Korea)

    Objective: To determine whether olfactory deficits may be related to the cognitive impairment in de novo Parkinson’s disease patients. Background: Hyposmia is highly prevalent in…
  • 2017 International Congress

    Quantitative measures of brain MRI as a predictive factor of cognitive outcomes after Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s disease

    L. Weinkle, J. Tanabe, B. Hoyt, J. Thompson, J. Honce, O. Klepitskaya (Aurora, CO, USA)

    Objective: To explore whether pre-surgical white matter lesion volume, measured quantitatively on brain MR images, is predictive of cognitive outcomes following subthalamic nucleus deep brain…
  • 2017 International Congress

    Clinical Experience with Initiation of Carbidopa/Levodopa Enteral Suspension in Parkinson’s Disease Patients with Cognitive Impairment

    P. Dowell, K. Lyons, R. Pahwa (Kansas City, KS, USA)

    Objective: To assess the safety and efficacy of carbidopa/levodopa enteral suspension (CLES) in Parkinson’s disease (PD) patients with cognitive impairment. Background: As Parkinson’s Disease progresses,…
  • 2017 International Congress

    Rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula: a case report

    T. Weissfeld, D. Kremens, J. McCall (Philadelphia, PA, USA)

    Objective: To report the case of a 75-year-old woman with rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula Background: Vascular malformations…
  • 2017 International Congress

    Predict cognitive decline with non-clinical markers in Parkinson’s disease

    T. Yousaf, G. Pagano, F. NIccolini, M. Politis (London, United Kingdom)

    Objective: In this study, we investigated whether [123I]FP-CIT single photon emission computed tomography (SPECT) imaging measures and CSF marker profiles predict CI in PD patients…
  • 2017 International Congress

    Relationship between Insulin-like Growth Factor-1 and characteristics of physical activity in patients with Parkinson’s disease

    K. Nagaki, M. Ikenaga, S. Fujioka, Y. Tsuboi (fukuoka, Japan)

    Objective: To clarify the characteristics of decreased physical activity and relationship between physical activity intensity and Insulin-like Growth Factor-1 (IGF-1) in patients with Parkinson's disease…
  • 2017 International Congress

    Higher risk of cognitive impairment in Parkinson’s disease with comorbid diabetes

    P. Schmidt, F. Cubillos, K. Lyons, C. Marras, T. Davis, E. Nelson, M. Okun (Miami, FL, USA)

    Objective: To determine the risk of cognitive impairment in individuals with Parkinson’s disease (PD) and diabetes. Background: Diabetes is associated with risk of cognitive impairment…
  • « Previous Page
  • 1
  • …
  • 101
  • 102
  • 103
  • 104
  • 105
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley